Targeted Therapies for Quieter Genomes
A bigger genome is sometimes easier to treat than a smaller one. Current methods of cancer therapy face challenges when treating the large majority of tumors that have quiet genomes. Cancers with a quiet genome often occur when a tumor suppressor is lost. Certain forms of targeted therapies look to target these lost tumor suppressors, but if the suppressor is missing, how does one target it? This has been a huge challenge in targeted therapies for cancer. Despite the challenges, targeted therapies are not impossible on the road to treating cancers with quieter genomes, and scientists and researchers continue their quest. To learn more about how scientists have adapted to target these quiet genomes, read here.